Misdiagnosis of hereditary angio-oedema type 1 and type 2

British Journal of Dermatology

Volumn 148, Issue 4, 2003, Pages 719-723

  Gompels, M M ^a   Lock, R J ^a   Unsworth, D J ^a   Johnston, S L ^a   Archer, C B ^b   Davies, S V ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

C1 inhibitor deficiency; C4; Hereditary angio oedema

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ANGIONEUROTIC EDEMA TYPE 1; ANGIONEUROTIC EDEMA TYPE 2; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC DISORDER; HUMAN; LABORATORY DIAGNOSIS; MALE; MEDICAL AUDIT; PRIORITY JOURNAL; RECURRENT DISEASE; SERODIAGNOSIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGE FACTORS; ANGIONEUROTIC EDEMA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C4; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INFANT; MALE; MEDICAL AUDIT; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SERPINS;

EID: 0037564573     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05231.x     Document Type: Article

References (15)

1. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996; 334: 1666-7.
2. Davis AE. C1-inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 66: 595-628.
3. Gompels MM, Lock RJ, Morgan JE et al. A multi-centre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 2002; 55: 145-7.
4. Kunschak M, Engl W, Maritsch F et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998; 38: 540-9.
5. Pitts JS, Donaldson VH, Forristal J et al. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement. J Clin Lab Med 1978; 92: 501-7.
6. De Filippi F, Castelli R, Cicardi M et al. Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor. Transfusion 1998; 38: 307-11.
7. Cicardi M, Mannucci PM, Castelli R et al. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate [see comments]. Transfusion 1995; 35: 209-12.
8. Cicardi M, Castelli R, Zingale LC et al. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997; 99: 194-6.
9. Bork K, Pitton M, Harten P et al. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 1999; 353: 1066-7.
10. Sánchez Palacios A, Schamann Medina F, García Marrero JA. Chronic angioedema. Three relevant cases. Allergol Immunopathol 1998; 26: 195-8.
11. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-32.
12. Sim TC, Grant JA. Hereditary angioedema: its diagnostic and management perspectives [see comments]. Am J Med 1990; 88: 656-64.
13. Morris GE, Slavin BM, Browse NL. Hereditary angioneurotic oedema: a neglected diagnosis. J Clin Pathol 1987; 40: 516-7.
14. Bork K, Barnstedt S-E, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356: 213-17.
15. Faye A, Abinun M. Current management of hereditary angioedema (C1-esterase inhibitor deficiency). J Clin Pathol 2002; 55: 266-70.